Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001358403-17-000079)

Filing Details

Accession Number:: 0001358403-17-000079
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-05-26 15:07:07
Reporting Period:: 2017-05-25

Filing Date:: 2017-05-26
Accepted Time:: 2017-05-26 15:07:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1358403	Bellicum Pharmaceuticals Inc	BLCM	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1295830	A Alan Musso	C/O Bellicum Pharmaceuticals, Inc. 2130 W. Holcombe Blvd., Ste. 800 Houston TX 77030	Cfo And Treasurer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-05-25	6,311	$12.24	54,908	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Represents shares sold to satisfy tax liabilities and withholding obligations in connection with vesting of 14,706 shares of common stock from the Restricted Stock Awards granted to the Reporting Person on December 17, 2014.
Includes 671 shares acquired under the Issuer's Employee Stock Purchase Plan on December 9, 2016.